BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 17161727)

  • 1. Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial.
    Moss SM; Cuckle H; Evans A; Johns L; Waller M; Bobrow L;
    Lancet; 2006 Dec; 368(9552):2053-60. PubMed ID: 17161727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCT.
    Duffy S; Vulkan D; Cuckle H; Parmar D; Sheikh S; Smith R; Evans A; Blyuss O; Johns L; Ellis I; Sasieni P; Wale C; Myles J; Moss S
    Health Technol Assess; 2020 Oct; 24(55):1-24. PubMed ID: 33141657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of mammographic screening from age 40 years on breast cancer mortality in the UK Age trial at 17 years' follow-up: a randomised controlled trial.
    Moss SM; Wale C; Smith R; Evans A; Cuckle H; Duffy SW
    Lancet Oncol; 2015 Sep; 16(9):1123-1132. PubMed ID: 26206144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial.
    Duffy SW; Vulkan D; Cuckle H; Parmar D; Sheikh S; Smith RA; Evans A; Blyuss O; Johns L; Ellis IO; Myles J; Sasieni PD; Moss SM
    Lancet Oncol; 2020 Sep; 21(9):1165-1172. PubMed ID: 32800099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A trial to study the effect on breast cancer mortality of annual mammographic screening in women starting at age 40. Trial Steering Group.
    Moss S
    J Med Screen; 1999; 6(3):144-8. PubMed ID: 10572845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials.
    de Koning HJ; Boer R; Warmerdam PG; Beemsterboer PM; van der Maas PJ
    J Natl Cancer Inst; 1995 Aug; 87(16):1217-23. PubMed ID: 7563167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effects of mammography screening: updated overview of the Swedish randomised trials.
    Nyström L; Andersson I; Bjurstam N; Frisell J; Nordenskjöld B; Rutqvist LE
    Lancet; 2002 Mar; 359(9310):909-19. PubMed ID: 11918907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2007; 7(1):1-32. PubMed ID: 23074501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized controlled trial of mammographic screening from age 40 ('Age' trial): patterns of screening attendance.
    Johns LE; Moss SM;
    J Med Screen; 2010; 17(1):37-43. PubMed ID: 20356944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Followup after 11 years--update of mortality results in the Stockholm mammographic screening trial.
    Frisell J; Lidbrink E; Hellström L; Rutqvist LE
    Breast Cancer Res Treat; 1997 Sep; 45(3):263-70. PubMed ID: 9386870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of mammographic surveillance services in women aged 40-49 years with a moderate family history of breast cancer: a single-arm cohort study.
    Duffy SW; Mackay J; Thomas S; Anderson E; Chen TH; Ellis I; Evans G; Fielder H; Fox R; Gui G; Macmillan D; Moss S; Rogers C; Sibbering M; Wallis M; Warren R; Watson E; Whynes D; Allgood P; Caunt J
    Health Technol Assess; 2013 Mar; 17(11):vii-xiv, 1-95. PubMed ID: 23489892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality.
    Tabár L; Vitak B; Chen HH; Yen MF; Duffy SW; Smith RA
    Cancer; 2001 May; 91(9):1724-31. PubMed ID: 11335897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tailored Breast Screening Trial (TBST)].
    Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
    Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 16-year mortality from breast cancer in the UK Trial of Early Detection of Breast Cancer.
    Lancet; 1999 Jun; 353(9168):1909-14. PubMed ID: 10371568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening.
    Alexander FE; Anderson TJ; Brown HK; Forrest AP; Hepburn W; Kirkpatrick AE; Muir BB; Prescott RJ; Smith A
    Lancet; 1999 Jun; 353(9168):1903-8. PubMed ID: 10371567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for breast cancer with mammography.
    Gøtzsche PC; Nielsen M
    Cochrane Database Syst Rev; 2011 Jan; (1):CD001877. PubMed ID: 21249649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for breast cancer with mammography.
    Gøtzsche PC; Nielsen M
    Cochrane Database Syst Rev; 2009 Oct; (4):CD001877. PubMed ID: 19821284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for breast cancer with mammography.
    Gøtzsche PC; Nielsen M
    Cochrane Database Syst Rev; 2006 Oct; (4):CD001877. PubMed ID: 17054145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammographic surveillance in women younger than 50 years who have a family history of breast cancer: tumour characteristics and projected effect on mortality in the prospective, single-arm, FH01 study.
    FH01 collaborative teams
    Lancet Oncol; 2010 Dec; 11(12):1127-34. PubMed ID: 21093374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefits and Harms of Breast Cancer Screening: A Systematic Review.
    Myers ER; Moorman P; Gierisch JM; Havrilesky LJ; Grimm LJ; Ghate S; Davidson B; Mongtomery RC; Crowley MJ; McCrory DC; Kendrick A; Sanders GD
    JAMA; 2015 Oct; 314(15):1615-34. PubMed ID: 26501537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.